Fundraising FoxDeerfield Management Company — 2025 Investments
7 investments dated 2025 · listed companies and verified rows first · show all
Adela develops blood-based tests for cancer detection using epigenetics and liquid biopsy technology, aimed at helping patients and clinicians detect and act on cancer earlier.
BiotechDigital HealthHealthtechMedical DevicesFoster City, US
Daniel Diniz De Carvalho(Executive Officer, Promoter)Scott Bratman(Executive Officer, Director)inAnne-Renee Hartman(Founder)inAlan Williams(Executive Officer)inLisa Alderson(Executive Officer, Director)inPriscilla Huang(Executive Officer)in
Board seatAndrew ElBardissi· per SEC Form D
Co-investorsDecheng CapitalF-Prime CapitalOrbiMedMenlo Ventures
Ascertain provides an agentic AI platform that automates healthcare administrative work such as prior authorizations, referrals, eligibility checks, and care coordination by integrating with existing systems and embedding human review.
AI & Machine LearningDigital HealthHealthtechNew York, US
Mark Michalski(Executive Officer, Director)inMarc Berger(Executive Officer)Gregg Fergus(Executive Officer, Director)Laurence Kraemer(Executive Officer)Carlos Dedesma(Executive Officer)Courtney Marcin(Director)
Board seatMoses AdubiJulian Harris· per SEC Form D
Co-investorsAegis Ventures
Excelsior Sciences develops automated chemistry technology for small-molecule discovery and manufacturing, targeting pharmaceutical and materials development.
AI & Machine LearningBiotechDeep Tech
Marty BurkeBartosz GrzybowskiMichael Foley(CEO)inJana Jensen(COO)in
Co-investorsKhosla VenturesSofinnova PartnersCornucopian Capital ManagementIllinois Ventures
Frontier is a drug discovery company developing small-molecule covalent drugs aimed at previously undruggable protein targets across the proteome.
AI & Machine LearningBiotechSouth San Francisco, US
Chris Varma, Ph.D.(Executive Officer, Director)Chris Varma(Co-founder, Chairman and CEO)inJim Winkler(Executive Officer)Johannes Hermann, Ph.D.(Executive Officer)Kevin Webster(Executive Officer)inGregory Chow(Executive Officer)
Co-investorsBerkeley CatalystDCVC (Data Collective)Droia VenturesFelicis VenturesMPM BioImpactRA Capital+2 more
myLaurel provides in-home medical care aimed at improving access for high-risk patients, working with clinicians and care teams.
Digital HealthHealthtechNew York, US
Juan Vallarino(Chief Executive Officer)in
Co-investorsAcumen AmericaBeresford VenturesCity LightFrist Cressey VenturesGV (Google Ventures)Revolution+2 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Perceive PharmaZed Industries
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.